Daniel Ajona
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Insights and perspectives into the discovery of complement-related biomarkers in cancer.
Journal: Current opinion in immunology
Published: May 26, 2025
Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance.
Journal: Cancer immunology research
Published: April 23, 2025
A mouse model to assess immunotherapy-related colitis.
Journal: Methods in cell biology
Published: January 25, 2025
Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors.
Journal: Molecular cancer
Published: January 17, 2025
The complement system in clinical oncology: Applications, limitations and challenges.
Journal: Seminars in immunology
Published: October 17, 2024
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer.
Journal: Signal transduction and targeted therapy
Published: October 10, 2024
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response.
Journal: Cancer immunology research
Published: March 15, 2024
Fasting and fasting-mimicking conditions in the cancer immunotherapy era.
Journal: Journal of physiology and biochemistry
Published: January 31, 2024
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer.
Journal: Frontiers in immunology
Published: August 04, 2023
Last Updated: 09/26/2026